Olesoxime

N/A

Report date: 2023/12/19 20:05:05
NME

Base Information

Drug NameOlesoxime
Drug Alias Name奥利索西olesoximaolesoximum奥索来肟奥来克辛 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsDiabetic NeuropathiesPeripheral Nervous System DiseasesSpinal Muscular Atrophies of Childhood +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPolandSerbia +[11] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrophos SaF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic NeuropathiesPeripheral Nervous System DiseasesSpinal Muscular Atrophies of Childhood +[7] 

Other Information

ATC CodeN/A
Related LinksWikipedia